Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Bourdon, you're posts are realistic. There's no basis for saying in a couple years ADXS will have 10x the valuation as today, the same as Kite's. That's the same as O'Connor saying ADXS would be valued at a $50 pps today. ADXS is already a late stage company, so we have two fully completed Phase 2 trials, and our valuation is based on that data while the CAR-T valuations are based on stronger data when they were at a similar stage.